- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07678723
Pupillary Light Reflex to Predict Post-Spinal Hypotension in Elective Cesarean Delivery
Pupillary Light Reflex for Predicting Hypotension Risk After Spinal Anesthesia for Elective Cesarean Section: A Prospective Observational Cohort Study
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Spinal anesthesia is the standard technique for elective cesarean delivery, yet it is frequently associated with maternal hypotension due to sympathetic blockade. According to the study protocol, spinal anesthesia-induced hypotension (SAIH) occurs in 50-90% of cases, and currently available predictors-including baseline blood pressure, BMI, and block height-demonstrate limited accuracy (AUC <0.65). The pupillary light reflex (PLR) is a sensitive indicator of autonomic nervous system balance, and pupillary reaction latency may reflect parasympathetic conduction efficiency. As noted in the protocol, no published studies have evaluated PLR as a predictor of hypotension after spinal anesthesia in obstetric patients.
This prospective observational cohort study aims to determine whether pre-anesthetic PLR parameters, particularly pupillary reaction latency, can predict the occurrence and severity of hypotension following spinal anesthesia for elective cesarean section. Additional pupillometry parameters-including baseline diameter, constriction velocity, and minimum diameter-will also be assessed. Measurements are obtained using a handheld pupillometer after 5 minutes of dark adaptation, with three readings taken at 60-second intervals.
Following spinal anesthesia with hyperbaric bupivacaine and fentanyl, maternal blood pressure is monitored every 5 minutes for the first 20 minutes. The primary outcome is hypotension, defined as a >20% decrease in systolic blood pressure. Secondary outcomes include severe hypotension, vasopressor requirements, maternal symptoms, and neonatal Apgar scores and umbilical artery pH.
Statistical analysis includes ROC curve evaluation, Youden's index for cutoff determination, and multivariate logistic regression. The study involves no interventions beyond routine care, and pupillometry is non-invasive and safe. Findings may support the development of a novel, objective, and clinically useful predictor for SAIH in obstetric anesthesia.
Studietype
Inschrijving (Geschat)
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
ASA II Term pregnancy ≥37 weeks Singleton pregnancy Elective cesarean section Age 18-45 years Written informed consent
Exclusion Criteria:
Emergency cesarean section Hypertensive disorders Diabetes mellitus Cardiovascular disease Neurological or autonomic disorders Ophthalmic disease Medications affecting autonomic function BMI >40 kg/m² Failed spinal anesthesia
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Elective Cesarean Section Cohort
Pregnant women (ASA II, term ≥37 weeks) undergoing elective cesarean section under spinal anesthesia.
Participants undergo pre-anesthetic pupillometry and routine perioperative monitoring.
No interventions are administered beyond standard clinical care.
|
This study does not involve any investigational drugs, devices, or therapeutic interventions.
Pupillometry is a non-invasive measurement performed as part of the observational assessment and is not considered an intervention.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Incidence of Hypotension After Spinal Anesthesia
Tijdsspanne: 0-20 minutes after spinal anesthesia
|
Hypotension defined as a >20% decrease in systolic blood pressure from baseline within the first 20 minutes after spinal anesthesia administration.
Blood pressure is measured every 5 minutes as per protocol.
|
0-20 minutes after spinal anesthesia
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Incidence of Severe Hypotension
Tijdsspanne: 0-20 minutes after spinal anesthesia
|
Severe hypotension defined as systolic blood pressure <80 mmHg or requiring vasopressor administration.
|
0-20 minutes after spinal anesthesia
|
|
Total Vasopressor Dose Administered
Tijdsspanne: Intraoperative period (first 20 minutes post-spinal)
|
Total amount of vasopressor medication administered to treat hypotension following spinal anesthesia.
|
Intraoperative period (first 20 minutes post-spinal)
|
|
Maternal Symptoms Associated With Hypotension
Tijdsspanne: Intraoperative period
|
Assessment of maternal symptoms including nausea, vomiting, dizziness, or discomfort associated with hypotension.
|
Intraoperative period
|
|
Neonatal Apgar Scores
Tijdsspanne: 1 minute and 5 minutes postpartum
|
Apgar scores at 1 and 5 minutes after delivery.
|
1 minute and 5 minutes postpartum
|
|
Umbilical Artery pH
Tijdsspanne: Immediately after delivery
|
Measurement of umbilical artery blood pH to assess neonatal acid-base status.
|
Immediately after delivery
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- DFM-IRB 00012367- 26-06-005
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .